AA
MRNA icon

Axiom Advisory’s Moderna MRNA Stock Holding History

Axiom Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.16M Buy
12,672
+198
+2% +$18.2K 0.01% 149
2024
Q2 		$1.58M Buy
+12,474
New +$1.58M 0.02% 126

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Axiom Advisory's MRNA Position: Q3 2024 in Review

Axiom Advisory increased its Moderna (MRNA) stake by 1.6% in Q3 2024, buying an estimated $18.2K and bringing the position to 12,672 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #149.

Axiom Advisory first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. The position peaked at $1.58M in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Axiom Advisory held 12,672 shares of Moderna worth $1.16M as of Q3 2024.
  • Axiom Advisory bought 198 Moderna shares in Q3 2024, an estimated $18.2K.
  • Moderna made up 0.01% of Axiom Advisory's portfolio in Q3 2024, its #149 holding.
  • Axiom Advisory first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
  • Axiom Advisory's Moderna position peaked at $1.58M in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Axiom Advisory's 13F filing for Q3 2024, filed 7 Oct 2024.